Assist in the development, implementation, and communication of HEOR strategies and tactics for pre-launch and in-line product(s) to enhance brand value propositions and optimize product reimbursement, formulary positioning, and utilization.
As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development and delivery of our products to our patients and customers. Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success. We realize that our strength and competitive advantage lie with our people. We support our employees in a number of ways to foster a healthy working environment, meaningful work, diversity and inclusion, mobility, networking and work-life balance. Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees.
Duties & Responsibilities:
Assist in the design, conduct, and reporting of high quality HEOR studies/ tools to generate scientific evidence to demonstrate the value of BI products.
Assist in the development of disease and product specific economic models.
Assist in the design and execution of research projects in support of CER strategies from a health outcomes perspective, encompassing health economics, patient-reported outcomes, and retrospective and prospective observational studies.
Assist in collaborations with cross-functional teams to ensure HEOR endpoints and methods are appropriately integrated into Phase II/III programs as well as observational studies.
Effectively communicate HEOR study results via scientific and/or other forums to various internal and external stakeholders.
Assist in assessment of marketplace for comparative effectiveness research (CER) requirements that affect BI products and integrate payers' needs into HEOR and Phase IV research plans.
Incorporate HEOR data into HQO communication tools/training and in pull through initiatives for disease management and managed markets marketing.
Follow and comply with all compliance laws and regulations
Advanced academic degree preferably doctoral (PhD, PharmD, MD) and/or Masters’ degree in Health Services Research, Health Economics Research, Epidemiology or related health outcomes field.
Minimum of four plus (4+) years of practical experience in conducting HEOR studies.
Strong communication (oral and written) and project management skills.
Travel (national and international) approximately 20% of the time .
Demonstrated expertise in health services research, pharmacoeconomic analyses, and patient-reported outcomes, prospective and retrospective observational research.
Strong methodological, quantitative and analytical skills.
Must be legally authorized to work in the United States without restriction.
Must be willing to take a drug test and post-offer physical (if required)
Must be 18 years of age or older
Boehringer Ingelheim is one of the world’s top 20 pharmaceutical companies and operates globally with approximately 50,000 employees. Since our founding in 1885, the company has remained family-owned and today we are committed to creating value through innovation in three business areas including human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. Since we are privately held, we have the ability to take an innovative, long-term view. Our focus is on scientific discoveries and the introduction of truly novel medicines that improve lives and provide valuable services and support to patients and their families. Employees are challenged to take initiative and achieve outstanding results. Ultimately, our culture and drive allows us to maintain one of the highest levels of excellence in our industry. We are also deeply committed to our communities and our employees create and engage in programs that strengthen the neighborhoods where we live and work. Boehringer Ingelheim, including Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA, Boehringer Ingelheim Animal Health USA, Inc., Merial Barceloneta, LLC and Boehringer Ingelheim Fremont, Inc. is an equal opportunity and affirmative action employer committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender identity or expression; affectional or sexual orientation; disability; veteran or military status, including protected veteran status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.
Boehringer Ingelheim is firmly committed to ensuring a safe, healthy, productive and efficient work environment for our employees, partners and customers. As part of that commitment, Boehringer Ingelheim conducts pre-employment verifications and drug screenings.
Internal Number: 182268
About Boehringer Ingelheim
Innovative medicines for people and animals have for more than 130 years been what the research-driven pharmaceutical company Boehringer Ingelheim stands for. Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies and to this day remains family-owned. Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. In 2016, Boehringer Ingelheim achieved net sales of around 15.9 billion euros. With more than three billion euros, R&D expenditure corresponds to 19.6 per cent of net sales.
Social responsibility comes naturally to Boehringer Ingelheim. That is why the company is involved in social projects such as the “Making More Health” initiative. Boehringer Ingelheim also actively promotes workforce diversity and benefits from its employees’ different experiences and skills. Furthermore, the focus is on environmental protection and sustainability in everything the company does.